Reviews Pitavastatin


No reviews yet.

Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009




Livalo Drug Description
LIVALO
(pitavastatin) Tablet, Film Coated for Oral use
DRUG DESCRIPTION
LIVALO (pitavastatin) is an inhibitor of HMG-CoA reductase. It is a synthetic lipid-lowering agent for oral administration.
The empirical formula for pitavastatin is C50H46CaF2N2O8
and the molecular weight is 880.98. Pitavastatin is odorless and occurs as white
to pale-yellow powder. It is freely soluble in pyridine, chloroform, dilute
hydrochloric acid, and tetrahydrofuran, soluble in ethylene glycol, sparingly
soluble in octanol, slightly soluble in methanol, very slightly soluble in water
or ethanol, and practically insoluble in acetonitrile or diethyl ether. Pitavastatin
is hygroscopic and slightly unstable in light.
The chemical name for pitavastatin is (+)monocalcium bis{(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}.
The structural formula is:









Each film-coated tablet of LIVALO contains 1.045 mg, 2.09 mg, or 4.18 mg of pitavastatin calcium, which is equivalent to 1 mg, 2 mg, or 4 mg, respectively of free base and the following inactive ingredients: lactose monohydrate, low substituted hydroxypropylcellulose, hypromellose, magnesium aluminometasilicate, magnesium stearate, and film coating containing the following inactive ingredients: hypromellose, titanium dioxide, triethyl citrate, and colloidal anhydrous silica.Last reviewed on RxList: 9/15/2009





Other reviews about Pitavastatin on wordpress

CoQ 10 and HIV-medication related changes in lipid levels: excerpt from the Canadian AIDS Treatment Information Exchange (CATIE) info sheet
  by jarebe
Below is an excerpt from the Canadian AIDS Treatment Information Exchange (CATIE) information sheet on the use of CoQ 10 by people with HIV/AIDS. This excerpt focuses particularly […]


TMCnet.com News Alert Service for 10/24/2008: "EU"
  by themailnews
Hello, These are the stories from the past 24 hours matching your selected keyword, "EU": 1Sttouch: The Vale Of Aylesbury Housing Trust Reduces Stock Costs As It Opts For […]


Statins for Cancer
  by Raymond Chang
This is a VERY LARGE topic to review (just like "cox-2 inhibitors" and "PPAR gamma agonists" because of the abundant data and complexity of the background biology - […]


Statins Update, Combos & CETP Inhibitors
  by extensointel
A recent update on statins combinations and CETP inhibitors Currently under development : Merck's CETP, Anacetrapib and Roche's Dalcetrapib Since the launch of Roches' s phase  III morbidity and mortality […]


Pitavastatin gains FDA approval
  by Larry Husten
The FDA today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with elevated or abnormal blood cholesterol […]


Pitavastatin prescribing information released by FDA
  by Larry Husten
The FDA has released prescribing information for pitavastatin, the newest statin on the US market approved yesterday. Pitavastatin appears to be as effective as atorvastatin and somewhat more […]


Another Cholesterol Drug to Join the U.S. Market
  by drugsinus
Who knew there would be another statin added to the crowded U.S. cholesterol-drug market? The FDA approved a new one yesterday. The medicine, known generically as pitavastatin, […]


Livalo Approved for High Cholesterol
  by timeinctemp
TUESDAY, Aug. 4 (HealthDay News) — Livalo (pitavastatin) is the newest statin to be approved by the U.S. Food and Drug Administration to treat high cholesterol. As with other […]


Recordati signs licensing agreement with Esteve
  by silico
Recordati has signed a licensing agreement with Esteve, a Spanish pharmaceutical company, for the marketing and sales in Spain of pitavastatin. According to Recordati, pitavastatin is a novel […]


Statins
  by ellocogringo
Recovering from Statin Poisoning Statins are a brain poison with the side effect of lowering cholosterol.  They are sold by pfizer and listed as "accepted medical procedure" by their […]



Other reviews about Pitavastatin on web:

Pitavastatin (usually as a calcium salt) is a novel member of the medication class of statins Like the other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses ... Pitavastatin - Wikipedia, the free encyclopedia


Enter your email address to subscribe to this blog and receive notifications of new posts by email. Pitavastatin gains FDA approval « CardioBrief


Available in Japan since 2003, the newest statin joins six others on the US market. FDA approves pitavastatin | theheart.org


Pitavastatin is just another statin drug, meaning it is a reductase inhibitor, designed to reduce cholesterol by the blocking of the mevalonate pathway. Pitavastatin


The U.S. Food and Drug Administration today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with ... FDA Approves New Cholesterol-Lowering Drug


Learn about the prescription medication Livalo (Pitavastatin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Livalo (Pitavastatin) Drug Information: Uses, Side Effects, Drug ...


Pitavastatin professional patient advice. Specific and up to date information about Pitavastatin. Complete Pitavastatin information from Drugs.com


You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this ... Pitavastatin - wikidoc


Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels Study to Compare the Efficacy of Pitavastatin With That of ...


Efficacy of Pitavastatin, a New HMG-CoA Reductase Inhibitor, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes Efficacy of Pitavastatin, a New HMG-CoA Reductase Inhibitor, on ...





Featured Reviews

Reviews Thiopental Sodium

Pentothal Drug Description Pentothal (thiopental sodium) for Injection, USP DRUG DESCRIPTION What are the possible side effects of thiopental (Pentothal)? You will remain under constant supervision during treatment with thiopental....
Read More  |  Review This
Reviews Tretinoin

Vesanoid Drug Description VESANOID® (tretinoin) Capsules WARNINGS 1. Experienced Physician and Institution Patients with acute promyelocytic leukemia (APL) are at high risk in general and can have severe adverse reactions to VESANOID...
Read More  |  Review This
Reviews Herceptin

Herceptin Drug Description HERCEPTIN® (trastuzumab) Intravenous Infusion Initial WARNING: CARDIOMYOPATHY, INFUSION REACTIONS, and PULMONARY TOXICITY Cardiomyopathy Herceptin can result in sub-clinical and clinical cardiac failure...
Read More  |  Review This
Reviews NeoTect

NeoTect Drug Description NEOTECT® Kit for the Preparation of Technetium Tc 99m Depreotide Injection DRUG DESCRIPTION NeoTect® (Kit for the Preparation of Technetium Tc 99m Depreotide Injection) is intended for use in the preparation...
Read More  |  Review This
Reviews Equagesic

Equagesic Drug Description DRUG DESCRIPTION Each tablet of Equagesic contains 200 mg meprobamate and 325 mg aspirin. The inactive ingredients present are cellulose, D&C Yellow 10, FD&C Red 3, FD&C Yellow 6, hydrogenated vegetable oil,...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....